Objectives To determine whether computer-based CT quantitation of change can improve on visual change quantification of parenchymal features in IPF. Methods Sixty-six IPF patients with serial CT imaging (6-24 months apart) had CT features scored visually and with a computer software tool: ground glass opacity, reticulation and honeycombing (all three variables summed as interstitial lung disease extent [ILD]) and emphysema. Pulmonary vessel volume (PVV) was estimated by computer only. Relationships between changes in CT features and forced vital capacity (FVC) were examined using univariate and multivariate linear regression analyses.
Introduction
The current accepted gold standard for identifying clinical deterioration in patients with IPF is the measurement of forced vital capacity (FVC) decline [1] . However recent advances in volumetric CT analysis using advanced computer algorithms Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00330-017-5053-z) contains supplementary material, which is available to authorized users. [2] appear to suggest that computer-based quantification of change in CT parenchymal patterns could similarly identify deterioration in IPF patients.
Only three studies to date have evaluated serial CT imaging in IPF and all have been constrained by small patient numbers or non-standardised CT acquisition parameters [3] [4] [5] . In the current study we aimed to explore the relationships between changes in various CT parameters, scored semi-quantitatively using visual analysis and quantitatively using computer analysis, with changes in key pulmonary function indices in a cohort of IPF patients.
Materials and methods

Study population
The study population consisted of all new patients with a multidisciplinary team diagnosis of IPF according to published guidelines [1] , presenting to the Royal Brompton Hospital over a four and a half year period (January 2007 to July 2011). Patients that had undergone two non-contrast, supine, volumetric thin section CT scans within a 6-24-month time period were selected. Exclusions are shown in the flowchart in Fig. 1 . Standardised pulmonary function protocols were utilised [2, 6] .
CT protocol
The CT scans were obtained using a 64-slice multiple detector CT scanner (Somatom Sensation 64, Siemens, Erlangen, Germany) or a 4-slice multiple detector CT scanner (Siemens Volume Zoom, Siemens, Erlangen, Germany). All scans were reconstructed using a high spatial frequency, B70 kernel (Siemens, Munich, Germany). All patients were scanned from lung apices to bases, supine, at full inspiration, with 1.0 mm section thicknesses using a peak voltage of 120kVp with tube current modulation (range 30-140 mA). Images were viewed at window settings optimised for the assessment of the lung parenchyma (width 1500 H.U.; level -500 H.U.).
Visual CT analysis
The CT scoring methodology has been previously described in detail [6] and involved quantifying the following parenchymal pattern extents: ground glass opacity, reticular pattern, honeycombing, emphysema, consolidation and traction bronchiectasis on a lobar basis (Fig. 2) . Parenchymal pattern extents were then averaged across six lobes to generate an average lung score for each pattern. Each CT was scored independently by two of four radiologists (AN, SLF, RE, ALB) with 5 to 9 years thoracic imaging experience, blinded to all clinical information and the time points of the serial CTs. For both visual and CALIPER analysis, total fibrosis extent represented the sum of reticulation and honeycombing, whilst total ILD extent additionally summed ground glass opacification.
Consensus formulation for visual scores involved identifying systematic biases in visual scores by plotting the spread of differences in parenchymal pattern scores between observers. The most disparate 5% (two standard deviations) of values were arbitrated by a third scorer for all parameters, thereby minimising bias among the original scorers. If a single parenchymal subtype extent was changed by consensus, the other parameters were modified, following CT review, to retain an overall sum of 100% for the four parenchymal subtypes. Similarly, if the lobar percentages of total interstitial disease or emphysema varied, the other parameter extent was rescored [7] .
Visual lobar CT scores were adjusted prior to statistical analysis to account for the contribution made by each lobe to total lung volume in health. As fibrosis develops, and, in the case of IPF, shrinks the lower lobes disproportionately, the true extent of lung fibrosis can be underestimated when using volumetric scoring systems. The shrunken contracted lower lobes contribute relatively smaller volumes toward the total lung volume than would be the case in health. As a consequence, lower lobes that might have been 25% of the lung volume in health, when shrunken to 10% of the total lung volume secondary to fibrosis, cannot reflect the true extent of disease within the lungs when using a volumetric score, as was the case with computer analysis, and traditional visual scoring of 5 axial CT sections. Lobar scores, as used in the visual scoring of CT scans in the current study, however, more accurately relate the extent of fibrosis within the lung, as each lobe is categorised as a discrete unit, regardless of its postfibrosis induced volume loss. A potential inaccuracy with visual lobar scoring lies in the relatively high proportional weighting given to the middle lobes, which are each quantified as one sixth of the lung. To account for this, the lobar scores of each individual visual scorer were adjusted to reflect the physiological contribution of each lobe to the total lung volume in health (Supplementary Table 1) , as characterised using scintigraphic and gas dilution techniques [7] . Therefore the right upper lobe scores were multiplied by 16.4/16.7, where 16.4% represented the physiological volume of the right upper lobe in health and 16.7% represented a sixth of the lung volume. The left upper and middle lobes were considered together and adjusted accordingly.
Computer CT analysis CALIPER data processing steps have been previously described and involve extraction of the lung from the surrounding thoracic structures and segmentation into upper, middle and lower zones. Lung segmentation was performed with an adaptive density-based morphological approach [8] whilst airway segmentation involved iterative three-dimensional region growing, density thresholding (thresholds including -950HU and -9 6 0 H U ) a n d c o n n e c t e d c o m p o n e n t s a n a l y s i s . Pulmonary vessels were extracted using optimised multi-scale tubular structure enhancement filters [9] . Parenchymal tissue type classification was applied to 15x15x15 voxel volume units using texture analysis, computer vision-based image understanding of volumetric histogram signature mapping features and 3D morphology [10] .
Computer evaluation of chest CTs by CALIPER [5] quantified ground glass opacity, reticular pattern, honeycombing and the pulmonary vessel volume (PVV). The PVV represented the total volume of pulmonary arteries and veins, excluding vessels, at the lung hilum. PVV was also subanalysed according to vessel location and vessel size. Using the carina as a landmark, vessels were defined as belonging to the upper zones if they were located above the carina. The distance between the carina and the lowermost CT section containing lung parenchyma was equally divided and used to demarcate the middle and lower zones of the lung. Similarly, vessels were examined according to cross-sectional area thresholds of <5mm 2 , 5-10mm 2 , 10-15mm 2 , 15-20mm 2 , >20mm 2 . CALIPER analysis also quantified three grades of low parenchymal attenuation. Grade 2 and 3 low attenuation areas have previously been shown to correspond to emphysema scored visually, whilst grade 1 low attenuation captured areas that corresponded to lung that appeared morphologically normal on CT [6] . CALIPER did not include quantification of consolidation or traction bronchiectasis.
Calculation of change in CT and pulmonary function variables
All CT variables (both visual and computer-derived) were computed as a percentage of the total lung volume except traction bronchiectasis, which was scored using a categorical 4 point scale [7] . Changes in all CT and lung function variables were expressed as absolute change per year (by dividing by the time interval between examinations), whilst FVC and DLco change was also expressed as relative change per year using volume measurements, rather than percent predicted values. Fig. 2 A CT pattern of ground glass with overlaid reticulation is evident in both lower lobes. So called Bground glass with texture^reflects the observation that, as opposed to areas of pure ground glass opacities, which appear smooth, the topology arising from overlaid reticulation is more complex and textured. Associated fibrosis is evident from the localised traction bronchiectasis in the right lower lobe (adjacent to asterisk). Visual scorers categorised such a pattern as reticulation, whilst the computer scored the pattern predominantly as ground glass opacity
Statistical analysis
Data are given as medians or means with standard deviations, or numbers of patients with percentages where appropriate. Interobserver variation for visual scores was assessed using the single determination standard deviation [11] . Mean population differences between patients with and without emphysema were measured using the Students T-test for continuous variables and the Chi-squared test for categorical variables. Univariate and multivariate linear regression analysis were used to investigate relationships between the three data sets: quantitative CT change, visual CT change and change in forced vital capacity. Statistical analyses were performed with STATA (version 4, StatCorp, College Station, TX, USA).
Results
Population demographics
Demographic data, mean visual CT score change, computer score change and pulmonary function test data are provided in Table 1 . Interobserver variation values for the visual scores are shown in Supplementary Table 2. The median patient age was 66 years and 80% of patients were male. The mean interval between CTs and pulmonary function tests was the same at 1.1 years.
Morphological and functional longitudinal change
The amount of normal lung characterised visually and by computer decreased by 7.9% and 8.6% per year, respectively, in absolute terms. Computer analysis identified slightly more yearly change in total ILD (7.8%) than visual scores (5.5%). With regard to individual ILD parenchymal patterns, computer-derived ground glass opacity was the pattern that increased the most per year (5.3%), followed by reticular pattern (2.3%)[ Table 1 ]. On visual scoring, however, traction bronchiectasis severity, measured on an 18-point scale, increased by 1.4% annually whilst reticular pattern and honeycombing increased annually by 4.3% and 2.1%, respectively ( Table 1) .
The pulmonary vessel volume (PVV), representing the percentage of the lung that was composed of vessels (computer score only), increased in absolute terms by 0.9% annually ( Table 1, Fig. 3 ). The pulmonary vessels comprised 4.7±1.6 percent of the lung on the baseline CT, which increased to 5.6 ±2.2 percent of the lung at the time of the second CT, equating to a relative increase in PVVof 19.1%. When PVV was quantified as a pure volumetric measure, without adjustment for total lung volume and conversion to percentage of the lung, the vessel volume was shown to increase from 176.0ml to 189.8ml, equating to a relative annual volume change of 7.8%.
Effects of emphysema presence on change in CT variables
Whist across the entire population, DLco levels showed a much larger relative annual decrease (18.7%) than FVC (10.4%) levels, the differences were exaggerated in patients in whom emphysema was visually identified on the baseline CT (Table 2) . Annualised relative DLco declines were similar in patients with (19.6%) and without emphysema (17.4%). However, annual relative FVC declines were markedly attenuated in patients with emphysema, with the differences showing a trend towards statistical significance (p=0.09). In patients with emphysema, a significantly smaller increase in traction bronchiectasis severity was noted across the two scans when compared to patients without emphysema (Table 2) .
Regression analyses
Univariate linear regression analysis was performed for all CT patterns to identify associations with FVC change (Table 3) . Visual CT parameters were less strongly linked to FVC change than computer-derived parameters, as measured by R 2 values (Table 3) . Change in traction bronchiectasis severity was found to be the strongest visual predictor of FVC change (R 2 =0.40).
Of all the visual and computer-derived measures of change on CT, change in PVV linked most strongly to FVC change (R 2 =0.57). When various expressions of PVV change were examined (change in absolute and relative percentage PVV and relative volumetric PVV change), absolute PVV change expressed as a percentage of the lung demonstrated the strongest relationship with relative FVC change. Accordingly, PVV change has henceforth been analysed as absolute PVV change. Measures of interstitial fibrosis, such as total ILD extent and reticular pattern, had significant FVC correlations using visual and computer-derived scoring methods, but linkages were weaker using visual scores (R 2 =0.16 and 0.25 respectively) than when scored by computer (R 2 =0.53 and 0.42 respectively) [ Table 3 ].
Multivariate linear regression analyses were performed to first identify visual and computer-derived parameters independently associated with FVC change in separate models (Table 4 ). An increase in traction bronchiectasis was the strongest visual variable linked to FVC decline, whilst an increase in PVV was the strongest computer-derived variable linked to FVC decline. Overall, computer-derived variables were found to better explain declines in FVC when compared to visual CT scores ( Table 4) .
Subanalysis of PVV change
The pulmonary vessels were sub-categorised in terms of vessel location and size, and relationships between the various subdivisions of vessels and FVC change were evaluated (Table 5 ). On univariate analysis of vessel location, vessels in the middle zones of the lung had the strongest linkage (R 2 =0.57) with FVC change, with results maintained on multivariate analysis. The strength of linkage between middle zone vessels and FVC change was similar in magnitude to univariate relationships between total PVV change and FVC change (R 2 =0.57). When vessels of differing size were explored in univariate analyses, all five subdivisions of vessel size had similar linkages with FVC change as judged by R 2 values (Table 5) . When each vessel size subdivision was examined in a bivariate model with total PVV change, total PVV change retained significance in every model, but only vessels between 10-15mm 2 remained weakly independently associated with FVC change (p=0.02).
Given the strength of the association between middle zone vessels and FVC change, a multivariate model incorporating change in vessel size subdivisions and middle zone vessels was examined; this demonstrated change in middle zone vessels to have the strongest independent association with FVC change (p<0.0001). The association between change in middle zone vessels and FVC change was maintained regardless of the presence (R 2 =0.42, p<0.0001) or absence (R 2 =0.63, p<0.0001) of emphysema. Following correction for baseline disease severity using either visual fibrosis extent, FVC or DLco in separate models, middle zone vessel change consistently maintained a strong independent link with FVC change (p<0.0001 in each model) in contrast to the variables representative of baseline disease severity.
Discussion
The current study has identified for the first time that in the longitudinal analysis of patients with IPF, an increase in a computer-derived variable, the pulmonary vessel volume, is the CT variable most strongly association with a decline in FVC, which itself is the current best measure of a clinical deterioration in a patient with IPF. Specifically, an increase in vessels in the mid-zones of the lungs demonstrated the strongest correlations with measures of functional decline.
Only one previous study, by Lee at al [3] , has evaluated change in CT parameters against change in pulmonary function indices. The study by Lee et al [3] evaluated patients with either histologically proven UIP or NSIP and demonstrated similar correlations between change in ILD extent and FVC change in both UIP and NSIP groups (R 2 =0.20 and R 2 =0.29 respectively) [3] . Results were similar to the equivalent visual correlations in the current study, but weaker than the correlations shown between computer-derived ILD extent and FVC change.
FVC decline is the parameter most widely used to evaluate disease progression in IPF [12] [13] [14] and whilst change in computer-derived variables were a stronger predictor of FVC change than change in visual scores, PVV change was the strongest single variable in the combined multivariate model. PVV increased by 0.9% of the lung in absolute terms, which reflected a relative increase of 19.1% by the time of the second CT. Absolute change of a magnitude of 0.9% of the lung would not be readily discernible to the human eye, and might explain the relative neglect of PVV as a marker of IPF progression to date. Furthermore, the observation that the actual volume of pulmonary vessels increased over time refutes the possibility that an overall reduction in total lung volume, consequent to the fibrotic process, could result in a relative 2.1 ± 3.7 0.4 ± 2.5* preservation of vascular volume, explaining the increase in PVV over serial CTs. Declines in FVC were most strongly related to an increase in vessel volume in the lung mid-zones, rather than change in vessel size. The findings suggest that firstly, any potential misclassification of reticulation as pulmonary vessels (which would be expected to be incorporated in the PVV <5mm 2 category) has a negligible functional effect when compared to a zonal increase in vessel volumes. Secondly, worsening pulmonary hypertension would be expected to increase vessel size rather than overall zonal vessel volumes, suggesting that our findings do not simply reflect an increase in pulmonary pressures. In addition, computer-derived quantitation of PVV excludes the large vessels at the lung hilum, therefore limiting the possibility that the increase in middle zone vessels reflects enlargement of the main pulmonary arteries. Importantly, regardless of the measure used to characterise baseline disease severity in IPF, an increase in the vessels in the lung mid-zone maintained strong independent functional associations.
Discordances between visual and computer-derived CT scores for change in individual ILD pattern extents were widest for change in ground glass opacity. The finding can partly be explained by a pattern that can be termed Bground glass with texture^, whereby a pattern of fine reticulation lies overlaid on ground glass opacities (Fig. 2) . Such a pattern was generally preferentially scored as ground glass opacity by computer analysis, and more often scored visually as reticulation, reflecting biases both from the radiologists visually scoring the CTs and the radiologists who initially trained the computer tool and derived its exemplars for ground glass opacity and reticular pattern. Differences in extent of honeycomb change between visual and computer-derived scores may be multifactorial. A degree of misclassification of cystic disease occurs with computer analysis with cyst walls labelled as reticular pattern, and cysts themselves labelled as emphysema or even normal lung. More importantly, as previously described, and analogous to baseline comparisons of visual and computer-derived scores [6] , longitudinal change of ILD extent and its components are under-represented by computer analysis when compared to visual scores as a consequence of differences in CT scoring methodology. As fibrosis extent increases over time, more of Several previous studies have confirmed the relative preservation of lung volumes that occurs secondary to the presence of emphysema in patients with IPF [15] [16] [17] . Our findings demonstrated that FVC decline (but not DLco decline) was attenuated in the presence of emphysema, though the relatively small patient numbers limit interpretation of the observation. However, given that FVC declines are both the primary clinical measure of deterioration in IPF [18] and represent an established drug trial end-point [1] , it is possible that the purported 30-40% of IPF patients that have emphysema [17, [19] [20] [21] may have important functional declines that are unrecognised. Our observations have importance both clinically and for drug trials, but will require validation and correlation with patient outcomes in larger prospective IPF cohorts.
An increase in traction bronchiectasis severity was the visual CT parameter that linked most strongly with FVC decline. Our findings are in line with previous work demonstrating linkages between traction bronchiectasis and mortality [22] [23] [24] [25] , traction bronchiectasis and fibroblastic foci profusion [26, 27] and between fibroblastic foci profusion and outcome in IPF [28] [29] [30] . Interestingly, in IPF patients with emphysema, traction bronchiectasis worsened at a significantly slower rate than in patients without emphysema. As previously observed [31] , it is conceivable that pre-existing emphysema-induced damage to the connective tissue scaffold of the lung may limit the degree to which airways can be distracted by supervening interstitial fibrosis when compared to nonfibrotic lung. Accordingly, over time, traction bronchiectasis may also progress at a reduced rate when emphysema coexists with fibrosis.
There were limitations to the current study. Firstly, the pulmonary function tests were performed within 3 months of the corresponding CT scan. Thus, when serial CT scans were compared, the time interval between CT imaging and pulmonary function testing may have been different. In practice, however, all change scores were normalised to a yearly change. Furthermore, when the mean and standard deviations of CT and pulmonary function test intervals were calculated, the results were similar (Table 1) . With regard to CT intervals assessed in the current study, ideally a narrower time frame such as 9-18 months would have been used to replicate the optimal clinical window within which a patient might routinely be re-scanned to assess disease progression. A follow-up period of 6-24 months was chosen for analysis, as it provided a great number of patients from which to analyse structure-function relationships.
In conclusion, the current study has demonstrated that an increase in an automated computer-derived variable, the pulmonary vessel volume, is the strongest CT determinant of FVC decline in IPF. Specifically, an increase in vessels in the middle zones of the lung demonstrated the strongest linkages with functional deterioration and was independent of measures of baseline disease severity. An increase in traction bronchiectasis severity was the visual CT score that demonstrated the strongest linkages with functional decline.
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Study subjects or cohorts overlap Some study subjects or cohorts have been previously reported in two studies: a structure function study and a mortality study. However these examined CT and functional variables at baseline and did not look at longitudinal change.
Methodology
• retrospective • observational • performed at one institution
